Search for Clinical Trial Results

Sponsored By

Leukemia, Mast-Cell - 13 Studies Found

Status Study
Completed Study Name: Phase II Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD
Condition: Leukemia, Mast-Cell
Date: 2005-09-14
Interventions:
  • Procedure: nonmyeloablative allogeneic hematopoietic cell transplant

Active, not recruiting Study Name: Phase II Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia
Condition:
  • Systemic Mastocytosis, Aggressive (ASM)
  • Leukemia, Mast Cell Date: 2005-10-03
    Interventions: Drug: Midostaurin Midostaurin is a broad-spectrum protein kinase inhibitor, acting on conventional PKC i
Completed Study Name: Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia
Condition:
  • Aggressive Systemic Mastocytosis
  • Mast Cell Leukemia
  • Date: 2013-03-05
    Interventions: Drug: brentuximab vedotin Brentuximab vedotin is an antibody with a covalently attached toxin. The antib
Active, not recruiting Study Name: Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
Condition: Leukemia
Date: 2008-10-28
Interventions: Drug: Midostaurin (PKC412) Midostaurin was provided as 25 mg soft gelatin capsules for oral administrati
Completed Study Name: Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis
Condition:
  • Aggressive Systemic Mastocytosis
  • Mast Cell Leukemia
  • Date: 2015-03-24
    Interventions:
    • Drug: Ibrutinib Given PO
Completed Study Name: Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (advSM) and Relapsed or Refractory Myeloid Malignancies
Condition:
  • Aggressive Systemic Mastocytosis
  • Systemic Mastocytosis-associated Hematologic Non-mast Cell
    Date: 2015-09-15
    Interventions: Drug: BLU-285
Completed Study Name: Patient-Reported Outcome Questionnaire for Systemic Mastocytosis
Condition:
  • Aggressive Systemic Mastocytosis (ASM)
  • SM w Assoc Clonal Hema Non-mast Cell Lineage Disease
    Date: 2015-02-26
    Interventions: Other: Interview Single interview lasting approximately one hour
Completed Study Name: Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies
Condition:
  • Acute Undifferentiated Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remission
  • Date: 2011-01-07
    Interventions:
    • Drug: deferasirox Given orally
Recruiting Study Name: Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Condition:
  • Acute Undifferentiated Leukemia
  • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
    • Date: 2009-05-09
    Interventions: Other: cytology specimen collection procedure Correlative studies
Terminated Study Name: Sunitinib in Treating Patients With Idiopathic Myelofibrosis
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Acute Undifferentiated Leukemia
  • Date: 2006-10-12
    Interventions: Drug: sunitinib malate Given PO
Next >>>